Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Advanced Solid Tumor 1

Interventions

pembrolizumab 135Carboplatin 111Paclitaxel 68Cisplatin 65Gemcitabine 62Pemetrexed 59Bevacizumab 50Docetaxel 47Fluorouracil 42Oxaliplatin 40Leucovorin 35Dexamethasone 35130-nm albumin-bound paclitaxel 34durvalumab 32atezolizumab 32Cetuximab 32Nivolumab 31Capecitabine 28Rituximab 27Cyclophosphamide 27Prednisone 26Fulvestrant 25enzalutamide 23Lenalidomide 23Letrozole 22venetoclax 21Irinotecan 21Doxorubicin 19ribociclib 16pomalidomide 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × CD3 Complex × 30 days × Clear all
NCT07408258 2026-06-04

Safety, Pharmacokinetics (PK), and Efficacy of ONC-783 in Advanced Solid Tumors

OncoC4, Inc.

Phase 1 Not yet recruiting
20 enrolled
Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡